Integra LifeSciences IART Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Integra LifeSciences’s reported figures.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's free cash flow?
- Integra LifeSciences (IART) reported free cash flow of -$5.05M in Q1 2026.
- How has Integra LifeSciences's free cash flow changed year-over-year?
- Integra LifeSciences's free cash flow increased by 87.4% year-over-year, from -$40.18M to -$5.05M.
- What is the long-term trend for Integra LifeSciences's free cash flow?
- Over 2 years (2021 to 2023), Integra LifeSciences's free cash flow has grown at a -47.4% compound annual growth rate (CAGR), from $264.41M to $73.09M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.